1.
Parimi S, Bondy S, Tsang E, McKenzie MR, Bachand F, Aparicio M, Duncan G, Sunderland K, Olson RA, Pai HH, Alexander AS, LaPointe V, Chi KN, Tyldesley S. Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer. CUAJ [Internet]. 2018 Dec. 4 [cited 2024 Apr. 18];13(10):E311-6. Available from: https://cuaj.ca/index.php/journal/article/view/5685